SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,972 | -81.7% | 29,400 | -63.2% | 0.00% | – |
| Q2 2023 | $382,400 | +70.4% | 79,833 | +101.7% | 0.00% | – |
| Q1 2023 | $224,419 | -10.5% | 39,580 | -11.6% | 0.00% | – |
| Q4 2022 | $250,818 | +5.8% | 44,789 | +34.7% | 0.00% | – |
| Q1 2022 | $237,000 | -91.4% | 33,260 | -89.9% | 0.00% | – |
| Q4 2021 | $2,756,000 | +85.5% | 330,787 | +55.0% | 0.00% | – |
| Q3 2021 | $1,486,000 | -77.4% | 213,454 | -22.5% | 0.00% | -100.0% |
| Q2 2021 | $6,568,000 | +39.6% | 275,410 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $4,705,000 | +21.4% | 228,522 | +44.5% | 0.00% | 0.0% |
| Q4 2020 | $3,875,000 | -3.9% | 158,135 | +11.0% | 0.00% | -33.3% |
| Q3 2020 | $4,033,000 | +5830.9% | 142,435 | +894.2% | 0.00% | – |
| Q2 2020 | $68,000 | +61.9% | 14,327 | +22.2% | 0.00% | – |
| Q1 2020 | $42,000 | -78.8% | 11,722 | -79.6% | 0.00% | – |
| Q4 2019 | $198,000 | -46.5% | 57,427 | -37.8% | 0.00% | -100.0% |
| Q3 2019 | $370,000 | +0.3% | 92,348 | -19.5% | 0.00% | 0.0% |
| Q2 2019 | $369,000 | – | 114,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |